Literature DB >> 21036134

Application of the immunological disease continuum to study autoimmune and other inflammatory events after vaccination.

Helen C Koenig1, Andrea Sutherland, Hector S Izurieta, Dennis McGonagle.   

Abstract

In vaccine safety monitoring, the evaluation of possible autoimmune events is challenging. Developing grouping systems based on pathophysiology, instead of organ systems, may enhance our ability to identify or verify associations between vaccines and adverse immunologically mediated events in clinical trials and post-licensure surveillance. Emerging data suggest that self-directed tissue inflammation occurs along a continuum from innate immune-driven diseases to adaptive immune-driven diseases. Herein, we develop this proposed classification for the vaccination setting in which inflammatory diseases are placed along a continuum according to the two major arms of the immune system, the innate immune arm (mediated by cells including neutrophils, macrophages and complement) and the adaptive immune arm (cell-mediated and humoral response). We incorporate hypersensitivity reactions and molecular mimicry vaccine-related reactions into this mechanistic scheme. We show how this could have important implications to assess mechanisms of potential immune-mediated adverse events following vaccination. Copyright Â
© 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036134     DOI: 10.1016/j.vaccine.2010.10.044

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Acute Demyelinating Events Following Vaccines: A Case-Centered Analysis.

Authors:  Roger Baxter; Edwin Lewis; Kristin Goddard; Bruce Fireman; Nandini Bakshi; Frank DeStefano; Julianne Gee; Hung Fu Tseng; Allison L Naleway; Nicola P Klein
Journal:  Clin Infect Dis       Date:  2016-09-01       Impact factor: 9.079

2.  Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination.

Authors:  Abdulla Watad; Gabriele De Marco; Hussein Mahajna; Amit Druyan; Mailam Eltity; Nizar Hijazi; Amir Haddad; Muna Elias; Devy Zisman; Mohammad E Naffaa; Michal Brodavka; Yael Cohen; Arsalan Abu-Much; Muhanad Abu Elhija; Charlie Bridgewood; Pnina Langevitz; Joanna McLorinan; Nicola Luigi Bragazzi; Helena Marzo-Ortega; Merav Lidar; Cassandra Calabrese; Leonard Calabrese; Edward Vital; Yehuda Shoenfeld; Howard Amital; Dennis McGonagle
Journal:  Vaccines (Basel)       Date:  2021-04-29

3.  Linear IGA bullous dermatosis potentially triggered by vaccination.

Authors:  Alberto Corrà; Veronica Bonciolini; Lavinia Quintarelli; Alice Verdelli; Marzia Caproni
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

4.  A Case of Acute Interstitial Nephritis After Two Doses of the BNT162b2 SARS-CoV-2 Vaccine.

Authors:  Filipe S Mira; Jóni Costa Carvalho; Patrícia Amaral de Almeida; Ana Carolina Pimenta; Iolanda Alen Coutinho; Carolina Figueiredo; Luís Rodrigues; Vítor Sousa; Emanuel Ferreira; Helena Pinto; Luís Escada; Ana Galvão; Rui Alves
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-12-03

Review 5.  Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients.

Authors:  Giulio Sansone; Domenico Marco Bonifati
Journal:  J Neurol       Date:  2022-05-03       Impact factor: 6.682

6.  SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature.

Authors:  Sithara Ramdas; Ryan Malcolm Hum; Abigail Price; Anna Paul; Jeremy Bland; Georgina Burke; Maria Farrugia; Jacqueline Palace; Alice Storrie; Pauline Ho; Emma Standing; James B Lilleker; Heinz Jungbluth
Journal:  Neuromuscul Disord       Date:  2022-09-05       Impact factor: 3.538

7.  In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases.

Authors:  Peter B McGarvey; Baris E Suzek; James N Baraniuk; Shruti Rao; Brian Conkright; Samir Lababidi; Andrea Sutherland; Richard Forshee; Subha Madhavan
Journal:  BMC Immunol       Date:  2014-12-09       Impact factor: 3.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.